CALIPER AND CARESTREAM SETTLE LAWSUITS

In the first lawsuit, filed in February 2010, Caliper, its wholly owned subsidiary, Xenogen, and Stanford University alleged that Carestream’s marketing and sales of its instrument systems induced infringement of seven imaging patents that are exclusively licensed to Xenogen by Stanford University. 

In the second lawsuit, filed in July 2010, Carestream alleged that Caliper’s Lumina XR system infringed a Carestream imaging patent (U.S. Patent No. 7,734,325).

To settle these lawsuits, Carestream and Caliper have agreed (i) to dismiss their respective claims and counterclaims; (ii) that Carestream will not market and sell in-vivo optical imaging systems for certain applications covered by patents licensed from Stanford by Xenogen and Caliper; and (iii) that Carestream will not assert that the Lumina XR system as currently configured and sold by Caliper infringes any of Carestream’s patents.

Caliper was represented by Mark Fox Evens and Eldora Ellison, Ph.D. of the law firm Sterne, Kessler, Goldstein & Fox, P.L.L.C. The two suits are (i)Caliper Life Sciences, et al. v. Carestream Health., Civil Action No.: 4:10-cv-02079-PJH (N.D.Ca.) & (ii)Carestream Health, Inc. v. Caliper Life Sciences, Case No.: 10-cv-00381(WMC)(SLC) (W.D.Wis.).

About CaliperLife Sciences

Caliper Life Sciences is a premier provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently.  Caliper is aggressively innovating new technology to bridge the gap betweenin vitro assays and in vivo results and then translating those results into cures for human disease.  Caliper’s portfolio of offerings includes state-of-the-art microfluidics, lab automation and liquid handling, optical imaging technologies, and discovery and development outsourcing solutions.  For more information please visit

www.caliperLS.com

.

Caliper is a registered trademark of Caliper Life Sciences, Inc.

Investor Contact:

Peter F. McAree

Senior Vice President and CFO

Caliper Life Sciences

774.278.2215

###